| http://www.w3.org/ns/prov#value | - Two open label non-controlled trials of methylphenidate reported an improvement in cognition, although four RCTs found no significant differences between the psychostimulant and placebo groups.A range of adverse effects were reported (details in paper).Authors' conclusionsBased on limited studies, methylphenidate was a possible treatment for apathy in older patients with dementia, but psychostimul
|
